Therapy for and prevention of traveler's diarrhea

Clinical Infectious Diseases

Volumn 45, Issue SUPPL. 1, 2007, Pages

  DuPont, Herbert L ^a,b,c,d  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MC 1 164 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETORPHAN; ATROPINE PLUS DIPHENOXYLATE; AZITHROMYCIN; BICOZAMYCIN; BISMUTH SALICYLATE; CIPROFLOXACIN; COTRIMOXAZOLE; CROFELEMER; DOXYCYCLINE; LEVOFLOXACIN; LOPERAMIDE; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMYCIN; RIFAXIMIN; STOMACH SECRETION INHIBITOR; ZALDARIDE MALEATE;

ACHILLES TENDON RUPTURE; ANTIBACTERIAL ACTIVITY; ARTHROPATHY; BEVERAGE; CHEMOPROPHYLAXIS; DRUG EFFICACY; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; GASTROINTESTINAL SYMPTOM; HIGH RISK POPULATION; HUMAN; INSOMNIA; IRRITABILITY; IRRITABLE COLON; MORBIDITY; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; RASH; REVIEW; SELF CARE; SIDE EFFECT; SINGLE DRUG DOSE; TRAVEL; TRAVELLER DIARRHEA; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DIARRHEA; ESCHERICHIA COLI INFECTIONS; HISTORY, 19TH CENTURY; HUMANS; MEXICO; TRAVEL; UNITED STATES;

EID: 34447129554     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518155     Document Type: Review

References (51)

1. Kean BH. The diarrhea of travelers to Mexico: summary of five-year study. Ann Intern Med 1963; 59:605-14.
2. Kean BH, Schaffner W, Brennan RW. The diarrhea of travelers. V. Prophylaxis with phthalylsulfathiazole and neomycin sulphate. JAMA 1962; 180:367-71.
3. Kean BH, Waters SR. The diarrhea of travelers. III. Drug prophylaxis in Mexico. N Engl J Med 1959; 261:71-4.
4. Kean BH, Waters S. The diarrhea of travelers. I. Incidence in travelers returning to the United States from Mexico. AMA Arch Ind Health 1958; 18:148-50.
5. DuPont HL, Formal SB, Hornick RB, et al. Pathogenesis of Escherichia coli diarrhea. N Engl J Med 1971; 285:1-9.
6. Dolin R, Blacklow NR, DuPont H, et al. Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis 1971; 123:307-12.
7. Cohen MB, Nataro JP, Bernstein DI, Hawkins J, Roberts N, Staat MA. Prevalence of diarrheagenic Escherichia coli in acute childhood enteritis: a prospective controlled study. J Pediatr 2005; 146:54-61.
8. Nataro JP, Mai V, Johnson J, et al. Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin Infect Dis 2006; 43:402-7.
9. Steiner TS, Nataro JP, Poteet-Smith CE, Smith JA, Guerrant RL. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest 2000; 105:1769-77.
10. DuPont HL, Haynes GA, Pickering LK, Tjoa W, Sullivan P, Olarte J. Diarrhea of travelers to Mexico: relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol 1977; 105:37-41.
11. Jiang ZD, Mathewson JJ, Ericsson CD, Svennerholm AM, Pulido C, DuPont HL. Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997. J Infect Dis 2000; 181:779-82.
12. Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Pallegar SR, DuPont HL. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. J Infect Dis 2002; 185:1681-3.
13. Adachi JA, Jiang ZD, Mathewson JJ, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis 2001; 32:1706-9.
14. Sack DA, Kaminsky DC, Sack RB, et al. Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med 1978; 298:758-63.
15. Rademaker CM, Hoepelman IM, Wolfhagen MJ, Beumer H, Rozenberg-Arska M, Verhoef J. Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea. Eur J Clin Microbiol Infect Dis 1989; 8:690-4.
16. Johnson PC, Ericsson CD, Morgan DR, DuPont HL, Cabada FJ. Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin. Antimicrob Agents Chemother 1986; 30:671-4.
17. Gorbach S, Edelman R. Travelers' diarrhea: National Institutes of Health Consensus Development Conference. Rev Infect Dis 1986:S109-233.
18. Ericsson CD, DuPont HL, Galindo E, et al. Efficacy of bicozamycin in preventing traveler's diarrhea. Gastroenterology 1985; 88:473-7.
19. DuPont HL, Jiang ZD, Okhuysen PC, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 2005; 142:805-12.
20. DuPont HL, Ericsson CD, Jiang Z-D, et al. Prevention of travelers' diarrhea with rifaximin: a phase 3, randomized, double-blind, placebo-controlled trial in US students in Mexico [abstract 516]. In: Abstracts of the American College of Gastroenterology annual meeting. Las Vegas; American College of Gastroenterology, 2006:259.
21. DuPont HL, Ericsson CD, Johnson PC, Bitsura JA, DuPont MW, de la Cabada FJ. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987; 257:1347-50.
22. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 1997; 4:41-3.
23. Kollaritsch H, Holst H, Grobara P, Wiedermann G. Prevention of traveler's diarrhea with Saccharomyces boulardii: results of a placebo controlled double-blind study [in German]. Fortschr Med 1993; 111:152-6.
24. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990; 22:53-6.
25. Procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded, and for establishing monographs [item 330.10], Federal Register, 29 March 1974.
26. DiCesare D, DuPont HL, Mathewson JJ, et al. A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico. Am J Gastroenterol 2002; 97:2585-8.
27. Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med 2000; 343:463-7.
28. DuPont HL, Ericsson CD, Mathewson JJ, Marani S, Knellwolf-Cousin AL, Martinez-Sandoval FG. Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrhea. Gastroenterology 1993; 104:709-15.
29. Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 1984; 86:1475-80.
30. DuPont HL, Reves RR, Galindo E, Sullivan PS, Wood LV, Mendiola JG. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med 1982; 307:841-4.
31. Ericsson CD, DuPont HL, Sullivan P, Galindo E, Evans DG, Evans DJ Jr. Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea. Ann Intern Med 1983; 98:20-5.
32. Gomi H, Jiang ZD, Adachi JA, et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 2001; 45:212-6.
33. Ericsson CD, DuPont HL, Mathewson JJ. Single dose ofloxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of traveler's diarrhea. J Travel Med 1997; 4:3-7.
34. Ericsson CD, DuPont HL, Mathewson J J. Optimal dosing of ofloxacin with loperamide in the treatment of non-dysenteric travelers' diarrhea. J Travel Med 2001; 8:207-9.
35. Ericsson CD, Johnson PC, DuPont HL, Morgan DR, Bitsura JA, de la Cabada FJ. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea: a placebo-controlled, randomized trial. Ann Intern Med 1987; 106:216-20.
36. Salam I, Katelaris P, Leigh-Smith S, Farthing MJ. Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea. Lancet 1994; 344:1537-9.
37. Wistrom J, Jertborn M, Hedstrom SA, et al. Short-term self-treatment of travellers' diarrhoea with norfloxacin: a placebo-controlled study. J Antimicrob Chemother 1989; 23:905-13.
38. DuPont HL, Jiang ZD, Ericsson CD, et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 2001; 33:1807-15.
39. Adachi JA, Ericsson CD, Jiang ZD, et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis 2003; 37:1165-71.
40. Krausse R, Ullmann U. In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001. Antimicrob Agents Chemother 2003; 47:2946-50.
41. DuPont HL. Azithromycin for the self-treatment of traveler's diarrhea. Clin Infect Dis 2007; 44:347-9.
42. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin: a double-blind, randomized, controlled trial. Ann Intern Med 1997; 126:697-703.
43. Kuschner RA, Trofa AF, Thomas RJ, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995; 21:536-41.
44. Ericsson CD, DuPont HL, Mathewson JJ, West MS, Johnson PC, Bitsura JA. Treatment of traveler's diarrhea with sulfamethoxazole and trimethoprim and loperamide. JAMA 1990; 263:257-61.
45. DuPont HL, Jiang Z-D, Belkind-Gerson J, et al. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol 2007; 5:451-6.
46. Petruccelli BP, Murphy GS, Sanchez JL, et al. Treatment of traveler's diarrhea with ciprofloxacin and loperamide. J Infect Dis 1992; 165:557-60.
47. Taylor DN, Sanchez JL, Candler W, Thornton S, McQueen C, Echeverria P. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann Intern Med 1991; 114:731-4.
48. Ericsson C, DuPont H, Okhuysen P, et al. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. Clin Infect Dis [in press].
49. Taylor DN, McKenzie R, Durbin A, et al. Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge. Clin Infect Dis 2006; 42:1283-8.
50. Gorbach SL. How to hit the runs for fifty million travelers at risk. Ann Intern Med 2005; 142:861-2.
51. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993; 328:1821-7.